Frequently Asked Questions

Helix offers a broad menu of genomic tests including hereditary cancer screening, cardiovascular genetics, pharmacogenomics, carrier screening, and proactive health screening panels — all powered by our Exome+ assay.

Providers can order Helix tests through our online portal or directly via integrated EHR workflows. Our team can help set up ordering pathways tailored to your health system.

After you provide your saliva sample, it is sent to our CAP-accredited, CLIA-certified lab where your DNA is extracted and sequenced using our Exome+ assay. Results are typically available within 2–4 weeks.

Most test results are available within 2–4 weeks from the time your sample arrives at our laboratory. Your ordering provider will be notified when results are ready.

Yes. Helix's Sequence Once, Query Often approach means your exome data is stored securely, enabling additional analyses from the same sample without re-collection.

Results are delivered via our secure provider portal and can be integrated directly into major EHR systems including Epic and Cerner through HL7/FHIR interfaces.

You can access your results through your healthcare provider or through the Helix patient portal. Your provider will walk you through the findings and any recommended next steps.

Absolutely. Your results can be shared directly with any healthcare provider. You can grant access through the Helix portal or request a copy of your report.

Coverage varies by plan and test type. Many health plans cover medically necessary genetic tests. Our team can help verify coverage and navigate prior authorization when needed.

Out-of-pocket costs depend on your insurance coverage and the specific test ordered. Helix offers transparent pricing and financial assistance programs for qualifying patients.

Billing models for population-scale programs are customized based on program scope, volume, and partnership structure. Contact our partnerships team to discuss options.

Yes. Helix maintains rigorous data security standards including HIPAA compliance, SOC 2 certification, and advanced encryption. Your genetic data is never sold to third parties.

All research use of data requires IRB approval and appropriate consent. Helix maintains strict de-identification protocols and data governance frameworks for all partner collaborations.

Yes. You can request deletion of your genetic data at any time by contacting our support team. We will process your request in accordance with applicable regulations.

Helix partners with health systems to launch population genomics programs, integrate genomic data into clinical workflows, and enable research. Contact our partnerships team to explore how we can work together.

Implementation includes program design, clinical workflow integration, provider education, participant enrollment, and ongoing support. Most programs launch within 3–6 months.

Yes. Helix's Genosphere platform provides access to one of the world's largest clinico-genomic datasets, supporting drug target discovery, clinical trial recruitment via Recall by Genotype, and real-world evidence studies.